Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited, has been awarded the prestigious Gold Medal by EcoVadis — the world’s most trusted provider of business sustainability ratings. The company achieved an exceptional score of 82 out of 100, placing it in the 98th percentile globally among more than 130,000 companies evaluated.
EcoVadis assesses organizations across four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. This recognition places Shilpa Pharma Lifesciences among the top global companies for sustainable business operations.
Mr. Keshav Bhutada, Executive Director and CEO of Shilpa Pharma Lifesciences, stated that sustainability and innovation are central to the company’s Contract Development and Manufacturing Organization (CDMO) growth strategy, particularly in collaborating with global innovator companies for their New Chemical Entity programs.
Bhutada added that the EcoVadis Gold Medal stands as a testament to the company’s efforts toward responsible manufacturing, ethical governance, and inclusive growth, further strengthening its position as a trusted global CDMO partner with sustainability at its core.
Disclaimer:
The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
